###begin article-title 0
TRAF6 Establishes Innate Immune Responses by Activating NF-kappaB and IRF7 upon Sensing Cytosolic Viral RNA and DNA
###end article-title 0
###begin p 1
Conceived and designed the experiments: HK TY KY JG TA KS TI YK OT JiI. Performed the experiments: HK TY. Analyzed the data: HK TY JG TA JiI. Contributed reagents/materials/analysis tools: KY HG AK TY TI YK BS OT SA YTY. Wrote the paper: HK JiI.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
In response to viral infection, the innate immune system recognizes viral nucleic acids and then induces production of proinflammatory cytokines and type I interferons (IFNs). Toll-like receptor 7 (TLR7) and TLR9 detect viral RNA and DNA, respectively, in endosomal compartments, leading to the activation of nuclear factor kappaB (NF-kappaB) and IFN regulatory factors (IRFs) in plasmacytoid dendritic cells. During such TLR signaling, TNF receptor-associated factor 6 (TRAF6) is essential for the activation of NF-kappaB and the production of type I IFN. In contrast, RIG-like helicases (RLHs), cytosolic RNA sensors, are indispensable for antiviral responses in conventional dendritic cells, macrophages, and fibroblasts. However, the contribution of TRAF6 to the detection of cytosolic viral nucleic acids has been controversial, and the involvement of TRAF6 in IRF activation has not been adequately addressed.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
Here we first show that TRAF6 plays a critical role in RLH signaling. The absence of TRAF6 resulted in enhanced viral replication and a significant reduction in the production of IL-6 and type I IFNs after infection with RNA virus. Activation of NF-kappaB and IRF7, but not that of IRF3, was significantly impaired during RLH signaling in the absence of TRAF6. TGFbeta-activated kinase 1 (TAK1) and MEKK3, whose activation by TRAF6 during TLR signaling is involved in NF-kappaB activation, were not essential for RLH-mediated NF-kappaB activation. We also demonstrate that TRAF6-deficiency impaired cytosolic DNA-induced antiviral responses, and this impairment was due to defective activation of NF-kappaB and IRF7.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Thus, TRAF6 mediates antiviral responses triggered by cytosolic viral DNA and RNA in a way that differs from that associated with TLR signaling. Given its essential role in signaling by various receptors involved in the acquired immune system, TRAF6 represents a key molecule in innate and antigen-specific immune responses against viral infection.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Akira1">[1]</xref>
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Bowie1">[3]</xref>
###xml 740 743 725 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato1">[4]</xref>
###xml 745 748 730 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kumagai1">[5]</xref>
Innate immune responses to viruses are triggered when the host recognizes specific viral nucleic acid and surface glycoprotein structures, called pathogen-associated molecular patterns (PAMPs) [1]-[3]. After viral infection, pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs), RIG-I-like helicases (RLHs), and cytosolic DNA sensor proteins, recognize viral PAMPs and then activate various transcription factors, including nuclear factor-kappaB (NF-kappaB) and interferon (IFN) regulatory factors (IRFs), to induce the production of proinflammatory cytokines and type I IFNs (IFNalpha and IFNbeta), respectively. Several lines of evidence indicate that PRRs recognize viral nucleic acids in a cell-type-specific manner [4], [5]. TLR7 and TLR9 are responsible for detection of viral RNA and DNA, respectively, in the endosomal compartments of plasmacytoid dendritic cells (pDCs), whereas RLHs detect viral RNA in the cytosol of conventional DCs (cDCs), macrophages, and fibroblasts.
###end p 9
###begin p 10
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai1">[6]</xref>
###xml 501 504 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Deng1">[7]</xref>
###xml 506 509 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Lamothe1">[8]</xref>
###xml 606 609 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Wang1">[9]</xref>
###xml 611 615 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kanayama1">[10]</xref>
###xml 793 797 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takaoka1">[11]</xref>
###xml 886 890 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai2">[12]</xref>
###xml 892 896 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Honda1">[13]</xref>
###xml 904 908 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Honda1">[13]</xref>
###xml 920 924 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Uematsu1">[14]</xref>
###xml 979 983 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Hoshino1">[15]</xref>
During TLR7 and TLR9 signaling, TLRs bind to their ligand and then interact with the adaptor protein called myeloid differentiation primary response gene 88 (MyD88) [6]. MyD88 then recruits members of the IL-1 receptor-associated kinase (IRAK) family such as IRAK1 and IRAK4, which activate TNF receptor-associated factor 6 (TRAF6). TRAF6 is an E3 ubiquitin ligase that catalyzes the formation of Lys-63-linked polyubiquitination on TRAF6 itself and IkappaB kinase gamma (IKKgamma also known as NEMO) [7], [8]. Subsequently, a complex of TAK1, TAK1 binding protein 2 (TAB2), and TAB3 is recruited to TRAF6 [9], [10]. TAK1 activates the IKK complex, leading to NF-kappaB activation and induction of proinflammatory cytokine expression, which is also enhanced by TRAF6- and MyD88-activated IRF5 [11]. In addition, upon viral infection, TRAF6 forms a complex with IRF7 together with MyD88 [12], [13], IRAK4 [13], and IRAK1 [14]. IRF7 is then phosphorylated by IRAK1 and/or IKKalpha [15], which result in dimer formation and nuclear translocation of IRF7, leading to the production of type I IFNs. Thus, TRAF6 plays a pivotal role in TLR7 and TLR9 signaling.
###end p 10
###begin p 11
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yoneyama1">[16]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yoneyama2">[17]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Hornung1">[18]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Pichlmair2">[19]</xref>
###xml 463 467 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai3">[20]</xref>
###xml 468 472 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Meylan1">[23]</xref>
###xml 843 846 832 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Bowie1">[3]</xref>
###xml 935 940 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf3</italic>
###xml 940 943 929 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1060 1064 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Oganesyan1">[24]</xref>
###xml 1066 1070 1051 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Saha1">[25]</xref>
###xml 1187 1191 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Oganesyan1">[24]</xref>
###xml 1240 1244 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Fitzgerald1">[26]</xref>
###xml 1246 1250 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sharma1">[27]</xref>
###xml 1360 1364 1339 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Seth1">[21]</xref>
###xml 1366 1370 1345 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Xu1">[22]</xref>
###xml 1372 1376 1351 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Rothenfusser1">[28]</xref>
###xml 1377 1381 1356 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yoshida1">[30]</xref>
###xml 1536 1540 1511 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Xu1">[22]</xref>
RLHs, such as RIG-I and the protein product of the melanoma differentiation-associated gene 5 (MDA5), contain two functional domains: an RNA helicase domain and a caspase recruitment domain (CARD) [16], [17]. The RNA helicase domain recognizes viral RNA, synthetic double-stranded RNA (dsRNA), and 5'-triphosphate RNA [18], [19], and the CARD domain interacts with the CARD-like domain of the IFNbeta promoter stimulator-1 (IPS-1, also known as MAVS/VISA/Cardif) [20]-[23]. Upon viral infection, IPS-1 associates with RIG-I or MDA5 at the mitochondrial outer membrane via the CARD-CARD interaction, which is essential for triggering downstream signaling that activates NF-kappaB and IRF. RLH signaling has been proposed to bifurcate at IPS-1 into the TRAF3-dependent IRF activation pathway and the TRAF6-dependent NF-kappaB activation pathway [3]. The TRAF3-dependent pathway has been genetically confirmed by experiments showing that Traf3-/- MEF cells show impaired production of type I IFNs but normal activation of NF-kappaB in response to viral infection [24], [25]. Furthermore, TRAF3 associates with TANK-binding kinase 1 (TBK1) and inducible IKK (IKKi, also known as IKKepsilon) [24], which phosphorylate and activate IRF3 and IRF7 [26], [27]. In contrast, the function of TRAF6 in innate immune responses to cytosolic viral RNA has been controversial [21], [22], [28]-[30], although mutation of TRAF6-binding sites in IPS-1 resulted in a marked reduction of IPS-1-induced NF-kappaB activation in a transient transfection assay [22]. Furthermore, the role of TRAF6 in IRF activation during RLH signaling has never been adequately addressed.
###end p 11
###begin p 12
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishii1">[31]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takaoka2">[34]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishii2">[32]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sun1">[35]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kumar1">[36]</xref>
In addition to RLH signaling, recent studies have reported that cytosolic DNA sensors initiate TLR9-independent innate immune responses [31]-[34]. Intracellular administration of viral DNA or synthetic double-stranded B-form DNA (B-DNA) triggers antiviral responses, including the production of proinflammatory cytokines and type I IFNs. IRF3 is activated by TBK1 and IKKi in response to B-DNA transfection [32], suggesting that cytosolic DNA activates signaling pathways similar to RLH signaling. Interestingly, while RLH signaling totally depends on IPS-1, contribution of IPS-1 to the cytosolic DNA sensing signaling has been controversial; one group reported dispensability of IPS-1 whereas the other reported partial involvement of IPS-1 in the cytosolic DNA sensing signaling [35], [36]. This suggests that cytosolic DNA and RNA are detected by different pathways. Therefore, the precise signaling mechanisms associated with DNA sensing, including the role of TRAF6, remain to be elucidated.
###end p 12
###begin p 13
In this study, we demonstrate that TRAF6 functions as a critical signal transducer for sensing both cytosolic RNA and DNA and thereby helps to trigger antiviral responses in a way that differs from that associated with TLR7 and TLR9 signalings.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
TRAF6 is involved in the RLH-mediated signaling pathway
###end title 15
###begin p 16
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato1">[4]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato2">[37]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Komatsu1">[38]</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 641 650 641 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1A</xref>
###xml 752 761 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1A</xref>
###xml 983 992 980 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1B</xref>
###xml 994 998 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato3">[39]</xref>
###xml 1000 1004 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Gitlin1">[40]</xref>
###xml 1133 1141 1130 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1206 1210 1203 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato3">[39]</xref>
###xml 1312 1320 1305 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1360 1369 1353 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1C</xref>
###xml 1441 1446 1434 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1446 1449 1439 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1484 1489 1477 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1489 1492 1482 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1552 1561 1545 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005674.s001">Figure S1</xref>
###xml 187 199 <span type="species:ncbi:11191">Sendai virus</span>
###xml 201 204 <span type="species:ncbi:11191">SeV</span>
###xml 291 294 <span type="species:ncbi:11191">SeV</span>
###xml 496 499 <span type="species:ncbi:11191">SeV</span>
###xml 689 692 <span type="species:ncbi:11191">SeV</span>
###xml 899 925 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 927 931 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1421 1424 <span type="species:ncbi:11191">SeV</span>
To address whether TRAF6 is involved in RLH-induced innate immune responses, we first assessed whether TRAF6 induces production of IL-6 and type I IFN in response to RNA virus infection. Sendai virus (SeV), a negative sense single-stranded RNA (ssRNA) virus, is recognized by RIG-I [4]. The SeV Cm mutant, which carries a mutated C protein, and the V-mutant, which lacks the V protein, were used because these viral accessory proteins suppress IFN responses [37], [38]. When infected with mutant SeV strains, Traf6-/- MEF cells showed no detectable induction of IL-6 production compared with the substantial induction in Traf6+/+ MEF cells (Figure 1A, top). Secretion of type I IFNs after SeV infection was significantly lower in the absence of TRAF6 (Figure 1A, middle and bottom). Furthermore, TRAF6 deficiency resulted in impaired activation of the IFNbeta promoter in response to infection with encephalomyocarditis virus (EMCV), a positive-sense ssRNA virus recognized by MDA5 (Figure 1B) [39], [40]. To further characterize the roles of TRAF6 in RLH signaling, synthetic double-stranded RNAs (dsRNAs) were tested. Poly I:C and in vitro transcribed dsRNA were detected by MDA5 and RIG-I, respectively [39]. IL-6 and IFNalpha production were significantly lower in response to transfection with poly I:C and in vitro-transcribed dsRNA using Lipofectamine (Figure 1C). Furthermore, the amount of viral C protein after SeV Cm infection of Traf6-/- MEF cells was higher than that in Traf6+/+ MEF cells at all time points tested after virus infection (Figure S1). Taken together, these results indicate that TRAF6 is crucial for both RIG-I- and MDA5-mediated antiviral responses.
###end p 16
###begin title 17
TRAF6 is involved in both RIG-I- and MDA5-mediated production of IL-6 and type I IFNs.
###end title 17
###begin p 18
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 213 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 213 216 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 220 225 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 225 228 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 472 477 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 477 480 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 484 489 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 489 492 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 664 672 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 692 700 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 902 910 872 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1</xref>
###xml 52 55 <span type="species:ncbi:11191">SeV</span>
###xml 352 356 <span type="species:ncbi:12104?1.0">EMCV</span>
A Traf6+/+ or Traf6-/- MEF cells were infected with SeV V- or Cm (MOI = 10) for 24 h. The amounts of IL-6 (top), IFNalpha (middle), and IFNbeta (bottom) present in the culture media were measured by ELISA. B Traf6+/+ or Traf6-/- MEF cells were transfected with the IFNbeta-luc reporter plasmid. At 48 h after transfection, MEF cells were infected with EMCV (MOI = 1) for 20 h. The cells were then harvested and analyzed for promoter activity using the luciferase assay. C Traf6+/+ or Traf6-/- MEF cells were treated with 10 microg/ml of LPS, 10 microg/ml of poly I:C alone (poly I:C) or transfected with 10 microg/ml of poly I:C (poly I:C+lipo), or 1 microg/ml of in vitro-transcribed dsRNA (in vitro-transcribed dsRNA+lipo) using Lipofectamine 2000. At 12 h after transfection, the amounts of IL-6 (upper) and IFNalpha (lower) present in the culture media were measured by ELISA. All results shown in Figure 1 indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. ND, not detected. NS, not significant. * = P<0.01.
###end p 18
###begin title 19
TRAF6 contributes to efficient elimination of RNA viruses
###end title 19
###begin p 20
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 278 281 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 305 308 305 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato3">[39]</xref>
###xml 435 444 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2A</xref>
###xml 559 568 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2B</xref>
###xml 661 670 657 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2C</xref>
###xml 355 378 <span type="species:ncbi:11176">Newcastle disease virus</span>
###xml 380 383 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 494 497 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 599 603 <span type="species:ncbi:12104?1.0">EMCV</span>
Because TRAF6 is required for efficient production of type IFNs during antiviral responses, we next analyzed the contribution of TRAF6 to eliminating RNA viruses. Quantification of viral replication by the plaque assay showed that viral yields were significantly higher in Traf6-/- MEF cells than in Traf6+/+ MEF cells at 48 and 72 h after infection with Newcastle disease virus (NDV), a negative-sense ssRNA recognized by RIG-I [39] (Figure 2A). The amount of IFNalpha secreted in response to NDV infection was significantly reduced in the absence of TRAF6 (Figure 2B). In addition, replication of EMCV was also significantly enhanced in the absence of TRAF6 (Figure 2C). Thus, TRAF6 contributes to effective elimination of RNA viruses that activate MDA5 pathway as well as those activate RIG-I pathway through production of sufficient amount of type I IFN.
###end p 20
###begin title 21
###xml 46 49 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 54 58 <span type="species:ncbi:12104?1.0">EMCV</span>
TRAF6 contributes to efficient elimination of NDV and EMCV.
###end title 21
###begin p 22
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 330 335 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 335 338 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 342 347 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 347 350 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 503 511 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2</xref>
###xml 100 103 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 380 384 <span type="species:ncbi:12104?1.0">EMCV</span>
A&B Traf6+/+ MEF cells, Traf6-/- MEF cells or those exogenously expressing TRAF6 were infected with NDV [MOI = 0.1 (A upper) or 1 (A lower, B)] for the indicated times. Viral titers in the culture media were determined using the plaque assay (A). The amounts of IFNalpha present in the culture media were measured by ELISA (B). C Traf6+/+ or Traf6-/- MEF cells were infected with EMCV (MOI = 0.01) for 24 h. Viral titers in the culture media were determined using the plaque assay. All results shown in Figure 2 represent the mean+/-SD of triplicate determinations and are representative of two independent experiments. NS, not significant. * = P<0.01. ** = P<0.05.
###end p 22
###begin title 23
During RLH signaling, TRAF6 plays a critical role in activating NF-kappaB and IRF7, but not in activating IRF3
###end title 23
###begin p 24
###xml 529 534 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 534 537 518 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 549 558 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3A</xref>
###xml 637 642 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 642 645 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 717 681 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3B and 3C</xref>
###xml 747 751 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IkBa</italic>
###xml 854 863 830 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3D</xref>
###xml 1248 1251 1216 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Deng1">[7]</xref>
###xml 1311 1316 1275 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1316 1319 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1363 1372 1327 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3C</xref>
###xml 1598 1607 1558 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3E</xref>
###xml 1713 1722 1669 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3F</xref>
###xml 2055 2059 2004 2008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Wang2">[41]</xref>
###xml 2061 2065 2010 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Zhao1">[42]</xref>
###xml 2339 2343 2284 2288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Honda2">[43]</xref>
###xml 2461 2465 2406 2410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yanai1">[44]</xref>
###xml 2777 2786 2716 2725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4A</xref>
###xml 3044 3049 2979 2984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 3049 3052 2984 2987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3140 3149 3075 3084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4B</xref>
###xml 3154 3156 3089 3091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005674.s002">S2</xref>
###xml 3218 3222 3153 3157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Honda2">[43]</xref>
###xml 3378 3383 3313 3318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 3383 3386 3318 3321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 3391 3396 3326 3331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 3396 3399 3331 3334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3434 3438 3369 3373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Zhao1">[42]</xref>
###xml 3631 3635 3566 3570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Paz1">[45]</xref>
###xml 3756 3760 3691 3695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Prakash1">[46]</xref>
###xml 3762 3771 3697 3706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4C</xref>
###xml 4052 4061 3987 3996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4C</xref>
###xml 4402 4407 4337 4342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4407 4410 4342 4345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 4415 4420 4350 4355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4420 4423 4355 4358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 4478 4483 4413 4418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4483 4486 4418 4421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 4535 4540 4470 4475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4540 4543 4475 4478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 4592 4601 4527 4536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4C</xref>
###xml 4686 4690 4621 4625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sato1">[47]</xref>
###xml 4715 4720 4650 4655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4720 4723 4655 4658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 4746 4751 4681 4686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 4751 4754 4686 4689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 4766 4775 4701 4710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4C</xref>
###xml 5092 5101 5027 5036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4D</xref>
###xml 5211 5215 5146 5150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Prakash1">[46]</xref>
###xml 5328 5337 5263 5272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 5366 5370 5301 5305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Marie1">[48]</xref>
###xml 5452 5461 5387 5396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">Figure 4E</xref>
###xml 5609 5618 5544 5553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 5638 5643 5573 5578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 5643 5646 5578 5581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 5681 5686 5616 5621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 5686 5689 5621 5624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 5841 5846 5772 5777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 5846 5849 5777 5780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 5963 5968 5890 5895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 5968 5971 5895 5898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 6022 6027 5949 5954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 6027 6030 5954 5957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 6109 6118 6036 6045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2B</xref>
###xml 686 689 <span type="species:ncbi:11191">SeV</span>
###xml 696 699 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 789 792 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1268 1271 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1563 1566 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1677 1680 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 3125 3128 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 3132 3135 <span type="species:ncbi:11191">SeV</span>
###xml 3330 3335 <span type="species:ncbi:9606">human</span>
###xml 4867 4872 <span type="species:ncbi:9606">human</span>
###xml 4902 4907 <span type="species:ncbi:10090">mouse</span>
###xml 5387 5390 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 5597 5600 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 6056 6059 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
Induction of proinflammatory cytokines and type I IFNs is essential for initial antiviral responses, which lead to the activation of adaptive immunity. Activation of transcription factors including NF-kappaB, IRF3, and IRF7 is a prerequisite for the efficient secretion of these cytokines. Therefore, we first checked whether TRAF6 is involved in activating NF-kappaB during RLH signaling. Activation of the NF-kappaB-driven luciferase promoter (NF-kappaB-luc) induced by intracellular administration of poly I:C was impaired in Traf6-/- MEF cells (Figure 3A). Induction of the nuclear DNA binding activity of NF-kappaB was abrogated in Traf6-/- MEF cells in response to infection with SeV Cm or NDV (Figure 3B and 3C). Furthermore, expression of IkBa, an NF-kappaB target gene induced by NDV infection was significantly reduced in the absence of TRAF6 (Figure 3D), These results indicate that TRAF6 is essential in the activation of NF-kappaB following RNA virus infection. To address whether the ubiquitin ligase activity of TRAF6 is required for NF-kappaB activation in response to RNA virus infection, we generated a ligase-deficient mutant of TRAF6 called T6Rm, in which both Cys-85 and His-87 within the RING domain were substituted with Ala [7]. Infection with NDV did not induce NF-kappaB activation in Traf6-/- MEF cells that ectopically expressed T6Rm (Figure 3C), suggesting that the E3 ubiquitin ligase activity of TRAF6 is required for NF-kappaB activation, as is the case in TLR signaling. Activation of c-Jun N-terminal kinase (JNK) in response to NDV infection was barely affected (Figure 3E). Interestingly, inactivation of RING finger of TRAF6 did not affect NDV-induced production of IFNalpha (Figure 3F) suggesting that Lys-63-linked polyubiquitination may not be involved in type I IFN production. Given that TRAF6 RING finger is required for NF-kappaB activation, this observation is consistent with previous reports showing that lack of p50, Rel, RelA or IKKbeta barely affected type I IFN production in response to viral infection [41], [42]. Therefore, TRAF6-mediated activation of NF-kappaB may not be essential for type I IFN production by RLH signaling. In contrast, lack of IRF3 or that of IRF7 resulted in significant reduction or abrogation of the viral infection-induced type I IFN production, respectively [43]. It has been reported that IRF5 is involved in production of IL-6 and type I IFN in macrophages but not in MEF cells [44]. Therefore, we next addressed whether TRAF6-deficiency affects activation of IRF 3 and IRF7 in MEF cells. Activation of the IFNbeta promoter (IFNbeta-luc) and the promoter containing multiple IFN-stimulated response elements (ISRE-luc) was impaired in response to poly I:C transfection in the absence of TRAF6 (Figure 4A), raising the possibility that TRAF6 is involved in the activation of IRF3 and IRF7, in addition to that of NF-kappaB. However, TRAF6 is dispensable for IRF3 activation because the dimerization of IRF3, an indicator of IRF3 activation, occurred normally in Traf6-/- MEF cells following either transfection with poly I:C or infection with NDV or SeV Cm (Figure 4B and S2). Although activation of IRF7 is critical for IFN production [43], IRF7 expression is barely detected during the initial stage of viral infection. To overcome this problem, human IRF7 (hIRF7) was ectopically expressed in Traf6+/+ and Traf6-/- MEF cells, as previously reported [42]. Activation of IRF7 was then determined using the anti-p-hIRF7 antibody, which recognizes phosphorylation of serine residues in the C-terminal region of hIRF7, an indicator of IRF7 activation [45]. Because both phosphorylated and unphosphorylated IRF7 became degraded upon stimulation as has been reported previously [46] (Figure 4C, left), we decided to evaluate levels of IRF7 activation based on the relative values that are expressed as the intensity of the band detected by anti-p-hIRF antibody at each time point divided by the intensity of the band detected by anti-IRF7 antibody at 0 h after stimulation (Figure 4C, right). This is because ability of TRAF6 to activate IRF7 should be evaluated amounts of phosphorylated IRF7 generated at certain period after stimulation as a consequence of both phosphorylation of IRF7 and degradation of unphosphorylated and phosphorylated IRF7 on the condition that amounts of IRF7 expressed at 0 h are almost equal in Traf6+/+ and Traf6-/- MEF cells. Relative amount of phosphorylated hIRF7 in Traf6-/- MEF cells was significantly lower than those in Traf6+/+ MEF cells following transfection with poly I:C (Figure 4C). Furthermore, heavily phosphorylated hIRF7, which migrates more slowly in SDS gels [47], was clearly evident in Traf6+/+ MEF cells, but not in Traf6-/- MEF cells (Figure 4C, left, second panel from the top). The reduced phosphorylation of IRF7 was not specific to human IRF7: the phosphorylation of mouse IRF7 (mIRF7), which is detectable as a more slowly migrating band on SDS gels, was also reduced when cells lacking TRAF6 and expressing exogenous mIRF7 were transfected with poly I:C (Figure 4D). Decay of mIRF7 levels after stimulation may be due to degradation of mIRF7 as has been reported previously [46]. Reduced activation of IRF7 in the absence of TRAF6 was further supported by the observation that expression of non-ifna4, which is regulated by IRF7 [48], in response to NDV infection was significantly reduced in the absence of TRAF6 (Figure 4E). These data indicate that TRAF6 is required for efficient activation of IRF7, but not of IRF3, in the RLH-mediated signaling pathway. NDV-induced non-ifna4 mRNA expression in Traf6-/- MEF cells was higher than that in Traf6-/- MEF cells at 24 h post-infection. This may be due to reduction of negative feed back that diminishes IFNalpha mRNA expression after viral infection in Traf6-/- MEF cells. However, despite this inversion at 24 h after infection, the amount of IFNalpha protein secreted from Traf6-/- MEF cells was significantly higher than that from Traf6-/- MEF cells in response to NDV infection at 24 h post-infection and thereafter (Figure 2B).
###end p 24
###begin title 25
TRAF6 is essential for NF-kappaB activation in RLH-mediated pathways.
###end title 25
###begin p 26
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 277 282 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 282 285 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 289 294 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 294 297 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 538 543 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 543 546 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 870 875 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 875 878 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 882 887 866 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 887 890 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 959 963 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IkBa</italic>
###xml 1013 1018 997 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1018 1021 1002 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1025 1030 1009 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1030 1033 1014 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1182 1187 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1187 1190 1171 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1202 1207 1186 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1207 1210 1191 1194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 327 330 <span type="species:ncbi:11191">SeV</span>
###xml 732 735 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 920 923 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1063 1066 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1288 1291 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
A Traf6+/+ or Traf6-/- MEF cells were transiently transfected with NF-kappaB-luc reporter plasmid. At 48 h after transfection, the cells were transfected with 10 microg/ml of poly I:C for 6 h. Cell lysates were then analyzed for promoter activity using the luciferase assay. B Traf6+/+ or Traf6-/- MEF cells were infected with SeV Cm (MOI = 10) for the indicated times. NF-kappaB binding activity was determined by EMSA. Nuclear extract obtained from wild-type MEF cells treated with TNFalpha (10 ng/ml) was used as a positive control. C Traf6-/- MEF cells were infected with retroviral vector carrying the puromycin resistance gene and encoding TRAF6, T6Rm, or no protein. Puromycin-resistant pools of MEF cells were infected with NDV (MOI = 5) for the indicated times. EMSAs were performed as described in (B) (left). TRAF6 and T6Rm expression was analyzed (right). D Traf6+/+ or Traf6-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. IkBa gene expression was assessed by real-time PCR. E Traf6+/+ or Traf6-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. Cell lysates were then analyzed for immunoblotting using anti-p-JNK antibody. F Traf6+/+ MEF cells, Traf6-/- MEF cells, and those exogenously expressing TRAF6 or T6Rm were infected with NDV (MOI = 5) for 24 h. The amounts of IFNalpha present in the culture media were measured by ELISA. Results shown in (A), (D), and (F) represent the mean+/-SD of triplicate determinations are representative of two independent experiments. * = P<0.01.
###end p 26
###begin title 27
TRAF6 is involved in type I IFNs production and IRF7 activation induced by RLH-mediated pathways.
###end title 27
###begin p 28
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 314 319 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 319 322 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 326 331 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 331 334 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 572 577 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 577 580 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 584 589 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 589 592 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1441 1446 1426 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1446 1449 1431 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1453 1458 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1458 1461 1443 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1894 1899 1875 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1899 1902 1880 1883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1906 1911 1887 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1911 1914 1892 1895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1983 1992 1964 1973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Non-ifna4</italic>
###xml 432 435 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 1519 1524 <span type="species:ncbi:10090">mouse</span>
###xml 1944 1947 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
A Traf6+/+ or Traf6-/- MEF cells were transiently transfected with IFNbeta-luc (left) or ISRE-luc (right) reporter plasmid. At 48 h after transfection, cells were transfected with 10 microg/ml of poly I:C (poly I:C+lipo) for 6 h. Cell lysates were then analyzed for promoter activity using the luciferase assay. B Traf6+/+ or Traf6-/- MEF cells were transfected with 10 microg/ml of poly I:C (poly I:C+lipo) (left) or infected with NDV (MOI = 5) (right) for the indicated times. Cell lysates were then prepared, and the dimerization of IRF3 was analyzed by native PAGE. C Traf6+/+ or Traf6-/- MEF cells were infected with retrovirus vectors encoding human IRF7 (hIRF7) carrying the puromycin resistance gene. Puromycin-resistant pools of MEF cells were treated with 10 microg/ml of poly I:C together with Lipofectamine 2000 (poly I:C+lipo) for the indicated times. Cell lysates were then prepared, and immunoblotting was performed using antibodies specific to phospho-hIRF7 (p-hIRF7), IRF7, TRAF6, and Tubulin. An open arrowhead denotes unphosphorylated forms and a closed arrowhead denotes phosphorylated forms of hIRF7 (left). Relative amounts of p-hIRF7 at various time points were expressed as the intensity of the band detected by anti-p-hIRF antibody at each time point divided by the intensity of the band detected by anti-IRF7 antibody at 0 h after stimulation (right). A result is representative of three independent experiments. D Traf6+/+ or Traf6-/- MEF cells were infected with retrovirus vectors encoding mouse IRF7 (mIRF7) carrying the puromycin resistance gene. Puromycin-resistant pools of MEF cells were treated with 10 microg/ml of poly I:C together with Lipofectamine 2000 (poly I:C+lipo) for the indicated times. Cell lysates were then prepared, and immunoblotting was performed using antibodies specific to IRF7 and Tubulin. A dot denotes phosphorylated forms of mIRF7. E Traf6+/+ or Traf6-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. Non-ifna4 gene expression was assessed by real-time PCR. Results shown in (A) and (E) indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. NS, not significant. * = P<0.01. ** = P<0.05.
###end p 28
###begin p 29
###xml 182 190 178 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1</xref>
###xml 239 247 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2</xref>
###xml 225 228 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 233 237 <span type="species:ncbi:12104?1.0">EMCV</span>
Taken together, in the absence of TRAF6, impaired activation of NF-kappaB and significantly reduced activation of IRF7 result in severely reduced expression of IL-6 and type I IFNs (Figure 1), as well as enhanced replication NDV and EMCV (Figure 2).
###end p 29
###begin title 30
TRAF6 forms a complex with TANK, TBK1, IKKi, and IRF7
###end title 30
###begin p 31
###xml 331 335 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Oganesyan1">[24]</xref>
###xml 337 341 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Saha1">[25]</xref>
###xml 343 347 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Guo1">[49]</xref>
###xml 515 519 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Xu1">[22]</xref>
###xml 787 796 783 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5A</xref>
###xml 882 891 878 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5A</xref>
###xml 917 921 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takaoka1">[11]</xref>
###xml 922 926 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Honda1">[13]</xref>
To understand the molecular mechanism of TRAF6-mediated IRF activation, we searched for TRAF6-associated proteins involved in RLH signaling. TRAF3, which is involved in the production of type I IFNs in response to RNA virus infection, associates with IPS-1, TBK1, IKKi, and TRAF family member-associated NF-kappaB activator (TANK) [24], [25], [49], all of which are required for production of type I IFNs. TRAF6 binds to IPS-1 through the latter's two consensus TRAF6-binding motifs (Pro-X-Glu-X-X-Aromatic/Acidic) [22]. These observations led us to investigate whether TRAF6, like TRAF3, associates with TBK1, IKKi, and TANK in addition to associating with IPS-1. Indeed, transient transfection experiments in 293T cells revealed that TRAF6 associates with IPS-1, TBK1, IKKi, and TANK (Figure 5A). TRAF6 did not bind IRF-3, whereas binding of TRAF6 to IRF7 was clearly detectable (Figure 5A), as previously reported [11]-[13]. These findings are consistent with our observation that RLH-mediated activation of IRF7, but not that of IRF3, is impaired in the absence of TRAF6. TRAF6 may mediate interaction of active TBK1/IKKi with IRF7 but not with IRF3.
###end p 31
###begin title 32
TRAF6 associates with TANK, TBK1, IKKi, and IRF7.
###end title 32
###begin p 33
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 632 635 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
A HEK293T cells were transiently transfected with the plasmid expressing Myc-tagged TRAF6 together with that encoding FLAG-tagged IPS-1, TBK1, IKKi, IRF7, IRF3, or TANK. Cell lysates were subjected to immunoprecipitation with anti-FLAG antibody, followed by immunoblotting. B Traf6+/+ and Traf6-/- MEF cells were transfected with IFNbeta-luc reporter plasmid together with the plasmid expressing RIG-IN, MDA5N, IPS-1, TBK1, or IRF7. At 48 h after transfection, cell lysates were prepared and analyzed for promoter activity using the luciferase assay. Values of luciferase activity when overexpressing each activator protein in TRAF6+/+ MEF cells were set to 100. C HEK293T cells were transfected with TRAF6-specific siRNA using RNAi MAX (+) or treated with RNAi MAX alone (-) (left). At 24 h after the initial transfection, the cells were further transfected with ISRE-luc reporter plasmid together with the plasmid expressing IKKi. At 24 h after the second transfection, cell lysates were prepared and analyzed for promoter activity using the luciferase assay. A value of luciferase activity when overexpressing IKKi protein without silencing TRAF6 was set to 100 (right). Results shown in (B) and (C) indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. * = P<0.01. ** = P<0.05.
###end p 33
###begin p 34
###xml 354 363 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5A</xref>
###xml 396 401 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 401 404 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 408 413 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 413 416 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 465 473 459 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1</xref>
###xml 649 658 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5B</xref>
###xml 753 762 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5B</xref>
###xml 1075 1084 1060 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5C</xref>
###xml 1201 1210 1186 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g005">Figure 5C</xref>
To identify functional interactions of TRAF6 with its binding partners described above, we investigated whether the TRAF6-associated protein-enhanced transcription of IFNbeta-luc, which is under the control of IRF-responsible elements, is affected by TRAF6 deficiency. IFNbeta-luc and an expression vector of one of the TRAF6-associated protein shown in Figure 5A were co-transfected into either Traf6+/+ or Traf6-/- MEF cells. Consistent with the results shown in Figure 1, TRAF6 deficiency inhibited the activation of IFNbeta promoter caused by overexpression of the N-terminal CARD domain of RIG-I (RIG-IN), that of MDA5 (MDA5N), IPS-1 and TBK1 (Figure 5B). In contrast, IRF7-induced IFNbeta promoter activation was not affected by TRAF6 deficiency (Figure 5B). Since overexpression of IKKi did not result in significant activation of IFNbeta promoter in MEF cells, we have performed similar experiments using HEK293T cells and ISRE-luc, which is under the control of IRF-responsible element. Endogenous TRAF6 expression in HEK293T cells was severely reduced using siRNA (Figure 5C, left), and IKKi-induced activation of the ISRE-driven promoter was significantly reduced in TRAF6-silencing cells (Figure 5C, right). Taken together, these results strongly suggest that TRAF6, like TRAF3, physically and functionally associates with RIG-I, MDA5, IPS-1, TANK, TBK1, and IKKi, and acts upstream of IRF7.
###end p 34
###begin title 35
TAK1 and MEKK3 are not essential for the RLH-mediated signaling pathway
###end title 35
###begin p 36
###xml 151 154 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Lamothe1">[8]</xref>
###xml 276 280 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Shim1">[50]</xref>
###xml 361 364 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Lamothe1">[8]</xref>
###xml 507 516 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3C</xref>
###xml 666 670 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai2">[12]</xref>
###xml 743 747 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 747 750 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 765 769 753 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 769 772 757 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 842 846 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 846 849 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1011 1020 995 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6A</xref>
###xml 1133 1142 1117 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6B</xref>
###xml 1259 1263 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Huang1">[51]</xref>
###xml 1491 1500 1467 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6C</xref>
###xml 1581 1585 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IkBa</italic>
###xml 1635 1639 1607 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ifnb</italic>
###xml 1644 1653 1616 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 1657 1662 1629 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 1662 1665 1634 1637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1741 1750 1713 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6D</xref>
###xml 885 888 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1115 1118 <span type="species:ncbi:11191">SeV</span>
###xml 1354 1357 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1545 1548 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
During Toll/IL-1R signaling, TRAF6 acts to function as an E3 ubiquitin ligase to conjugate Lys-63-linked polyubiquitin chains to TRAF6 and to IKKgamma [8]. Several lines of evidence indicate that TAK1 is involved in the activation of NF-kappaB induced by the TLR-TRAF6 signal [50], and that activation of TAK1 requires Lys-63-linked polyubiquitination of TRAF6 [8]. Thus, the ligase-deficient mutant T6Rm cannot activate TAK1 during TLR signaling. T6Rm also cannot mediate RLH-induced NF-kappaB activation (Figure 3C). Since it has been reported that Ubc13, a subunit of the E2 ubiquitin-conjugating enzyme complex, is required for TRAF6-mediated activation of IRF7 [12], we addressed whether TAK1 is also involved in the RLH pathway. We used Tak1-/- MEF cells and Tak1-/- MEF cells reconstituted with wild-type TAK1 via a retroviral vector (Tak1-/-+TAK1 MEF). In the absence of TAK1, NDV infection induced slightly higher nuclear NF-kappaB binding activity than that observed in control cells expressing TAK1 (Figure 6A). However, production of IL-6 and type I IFN in the absence of TAK1 was normal in response to SeV Cm infection (Figure 6B). Another MAP3K, MEKK3, has been shown to be involved in the TLR-dependent activation of NF-kappaB induced by TRAF6 [51]. We therefore assessed whether MEKK3 functions in RLH signaling. In the absence of MEKK3, NDV infection induced slightly higher levels of nuclear NF-kappaB binding activity than that observed in control cells expressing MEKK3 (Figure 6C). However, MEKK3-deficiency barely affected NDV infection-induced expression of IkBa, an NF-kappaB target gene, whereas expression of ifnb and non-ifna4 in Mekk3-/- MEF cells was significantly higher than in control cells expressing MEKK3 (Figure 6D).
###end p 36
###begin title 37
TAK1 and MEKK3 are not essential in RLH-mediated pathways.
###end title 37
###begin p 38
###xml 2 6 2 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 421 426 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 426 429 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 480 485 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 485 488 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 631 636 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 636 639 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 665 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 665 668 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 755 759 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ifnb</italic>
###xml 768 777 761 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 792 796 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IkBa</italic>
###xml 92 95 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 271 274 <span type="species:ncbi:11191">SeV</span>
###xml 515 518 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 698 701 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
A Tak1-/- MEF cells and those ectopically expressing TAK1 (Tak1-/-+TAK1) were infected with NDV (MOI = 5) for the indicated times. EMSAs were then performed. Expression of exogenous TAK1 is shown (right). B Tak1-/-+TAK1 MEF cells and Tak1-/- MEF cells were infected with SeV Cm (MOI = 10) for 24 h. The amounts of IL-6 (right), IFNalpha (middle), and IFNbeta (left) present in the culture media were measured by ELISA. C Mekk3-/- MEF cells and those ectopically expressing MEKK3 (Mekk3-/-+MEKK3) were infected with NDV (MOI = 5) for the indicated times. EMSAs were then performed. Expression of exogenous MEKK3 is shown (right). D Mekk3-/-+MEKK3 MEF cells and Mekk3-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. Expression of the ifnb (left), non-ifna4 (middle), and IkBa (right) genes was assessed by real-time PCR. Results shown in (B) and (D) indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. ND, not detected. * = P<0.01. ** = P<0.05.
###end p 38
###begin p 39
Taken together, these results indicate that although both TAK1 and MEKK3 are critically involved in NF-kappaB activation that occurs through the TLR/IL-1R-TRAF6 pathway, neither is essential for RLH-TRAF6-mediated NF-kappaB activation. Instead, these proteins may negatively regulate NF-kappaB activation. MEKK3 may also act as a negative regulator of the RLH-induced production of IFN.
###end p 39
###begin title 40
TRAF6 is involved in the cytosolic DNA sensing system
###end title 40
###begin p 41
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishii1">[31]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takaoka2">[34]</xref>
###xml 319 323 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishii2">[32]</xref>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7A</xref>
###xml 695 704 687 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7B</xref>
###xml 833 842 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7B</xref>
###xml 911 915 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifnb</italic>
###xml 1015 1024 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7C</xref>
###xml 1158 1167 1143 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7D</xref>
###xml 1259 1264 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1379 1384 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1435 1440 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1470 1473 <span type="species:ncbi:11191">SeV</span>
###xml 1478 1481 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
Recent studies indicate that cytosolic DNA triggers innate immune responses [31]-[34], including the production of type I IFNs. This led us to examine whether TRAF6 is involved in the signaling pathway triggered by cytosolic dsDNA. B-DNA, which forms a right-handed helical structure, induces production of type I IFNs [32]. In the absence of TRAF6, transfection with B-DNA induced a lower production of IL-6 and type I IFNs than that observed in control cells expressing TRAF6 (Figure 7A). We then analyzed the effect of TRAF6 deficiency on B-DNA-induced activation of NF-kappaB and IRFs. B-DNA-induced NF-kappaB activation was significantly lower in the absence of TRAF6 than in its presence (Figure 7B, left). Furthermore, transcription of IFNbeta-luc or ISRE-luc was barely enhanced in response to B-DNA in the absence of TRAF6 (Figure 7B, middle and right). Requirement of TRAF6 in efficient expression of Ifnb was also observed when MEF cells were transfected with IFN stimulatory DNA (ISD) instead of B-DNA (Figure 7C). Interestingly, B-DNA-induced production of IFNalpha did not require E3 ligase activity of TRAF6 as in the case with RLH signaling (Figure 7D). We could not observe that TRAF6 deficiency affected type I IFN production in response to HSV-1 infection and its replication (data not shown). This may be due to severe suppression of type I IFN production by HSV-1 (1-6 pg/ml (below quantitative range of ELISA) in HSV-1 infection, 600-1000 pg/ml in SeV and NDV infection).
###end p 41
###begin title 42
TRAF6 is involved in cytosolic dsDNA-induced innate immune responses.
###end title 42
###begin p 43
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 246 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 246 249 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 253 258 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 258 261 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 585 590 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 590 593 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 597 602 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 602 605 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 669 673 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifnb</italic>
###xml 723 728 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 728 731 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 743 748 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 748 751 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 994 1002 960 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7</xref>
A Traf6+/+ or Traf6-/- MEF cells were transfected with 10 microg/ml of B-DNA (B-DNA+lipo). At 12 h after transfection, the amounts of IL-6 (left), IFNalpha (middle), and IFNbeta (right) present in the culture media were measured by ELISA. B Traf6+/+ or Traf6-/- MEF cells were transiently transfected with NF-kappaB-luc (left), IFNbeta-luc (middle), or ISRE-luc (right) reporter plasmid. At 48 h after the initial transfection, MEF cells were transfected with 10 microg/ml of B-DNA (B-DNA+lipo) for 6 h. Cell lysates were then analyzed for promoter activity by the luciferase assay. C Traf6+/+ or Traf6-/- MEF cells were transfected with 5 microg/ml of ISD (ISD+lipo). Ifnb gene expression was assessed by real-time PCR. D Traf6+/+ MEF cells, Traf6-/- MEF cells, and those exogenously expressing TRAF6 or T6Rm were transfected with 10 microg/ml of B-DNA (B-DNA+lipo). At 12 h after transfection, the amounts of IFNalpha present in the culture media were measured by ELISA. All results shown in Figure 7 indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. ND, not detected. * = P<0.01. ** = P<0.05.
###end p 43
###begin p 44
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 159 168 159 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g008">Figure 8A</xref>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g008">Figure 8B</xref>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 403 412 403 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g008">Figure 8B</xref>
###xml 570 579 570 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 678 687 678 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g008">Figure 8C</xref>
We next addressed the role of TRAF6 in the activation of IRF3 and IRF7. B-DNA-induced dimerization of IRF3 was normal in both Traf6+/+ and Traf6-/- MEF cells (Figure 8A). However, impaired phosphorylation of exogenously expressed hIRF7 was observed in Traf6-/- MEF cells after B-DNA stimulation (Figure 8B). Moreover, the more slowly migrating form of hIRF7 was barely detectable in Traf6-/- MEF cells (Figure 8B), indicating that TRAF6 is involved in the B-DNA-induced activation of IRF7. Impaired activation of IRF7 is further supported by the fact that expression of non-ifna4, which is regulated by IRF7, is significantly lower in the absence of TRAF6 than in its presence (Figure 8C). These results indicate that TRAF6 is involved in B-DNA-mediated, as well as RLH-mediated, activation of NF-kappaB and IRF7.
###end p 44
###begin title 45
TRAF6 is involved in B-DNA-induced IRF7 activation.
###end title 45
###begin p 46
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 264 269 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 269 272 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 276 281 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 281 284 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 713 718 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 718 721 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 725 730 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 730 733 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 826 835 814 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Non-ifna4</italic>
A Traf6+/+ or Traf6-/- MEF cells were transfected with 10 microg/ml of B-DNA (B-DNA+lipo) for the indicated times. Cell lysates were then prepared, and dimerization of IRF3 was analyzed by native PAGE. Immunoblot analysis was performed using anti-IRF3 antibody. B Traf6+/+ or Traf6-/- MEF cells were infected with the retroviral vector encoding hIRF7 and containing the puromycin resistance gene. Puromycin-resistant pools of MEF cells were transfected with 10 microg/ml of B-DNA (B-DNA+lipo) for the indicated times. Cell lysates were prepared and immunoblotting was performed with antibodies specific for phospho-hIRF7 (p-hIRF7), IRF7, TRAF6, and Tubulin. An arrowhead denotes phosphorylated forms of hIRF-7. C Traf6+/+ or Traf6-/- MEF cells were transfected with 10 microg/ml of B-DNA (B-DNA+lipo) for the indicated times. Non-ifna4 gene expression was assessed by real-time PCR. Results shown in (C) indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. * = P<0.01.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
In this study, we clearly demonstrate that TRAF6 is involved in cytosolic RNA- and DNA-induced antiviral responses that lead to production of proinflammatory cytokines and type I IFNs. TRAF6 deficiency resulted in a significant reduction in the production of these cytokines in response to RNA virus infection or transfection with synthetic dsRNA or B-DNA. Consistent with these results, NF-kappaB activation induced by cytosolic RNA or DNA was impaired; moreover, the activation of IRF7, but not that of IRF3, was significantly reduced in the absence of TRAF6.
###end p 48
###begin p 49
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 211 214 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Seth1">[21]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Rothenfusser1">[28]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato2">[37]</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Komatsu1">[38]</xref>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 779 788 779 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005674.s003">Figure S3</xref>
###xml 1101 1106 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1106 1109 1106 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1133 1136 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1148 1164 1148 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2B and 2C</xref>
###xml 1243 1252 1239 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3C</xref>
###xml 1334 1343 1330 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g002">Figure 2B</xref>
###xml 1348 1350 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g004">4E</xref>
###xml 1432 1437 1425 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 1437 1440 1430 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1452 1461 1445 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g001">Figure 1B</xref>
###xml 1666 1670 1659 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yoshida1">[30]</xref>
###xml 302 305 <span type="species:ncbi:11191">SeV</span>
###xml 451 454 <span type="species:ncbi:11191">SeV</span>
###xml 567 570 <span type="species:ncbi:11191">SeV</span>
###xml 667 670 <span type="species:ncbi:11191">SeV</span>
###xml 882 885 <span type="species:ncbi:11191">SeV</span>
###xml 1031 1034 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1039 1043 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1060 1063 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1068 1072 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1192 1195 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1353 1357 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1586 1612 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Involvement of TRAF6 in RLH signaling has been controversial. In contrast to what we show here, two groups previously reported that TRAF6 is not involved in RLH-mediated antiviral responses by showing that Traf6-/- MEF cells produce normal levels of type I IFNs in response to infection with wild-type SeV [21], [28]. The discrepancy between our results and previous reports may be due to the use of different viruses. We used the Cm and V-mutants of SeV; these mutations inhibit antiviral responses in host cells [37], [38]. Previous studies utilized wild-type (WT) SeV. In fact, as in the previous reports, we found that production of type I IFNs in response to WT SeV infection was not affected by TRAF6 deficiency, whereas IL-6 production was impaired in Traf6-/- MEF cells (Figure S3). The precise reasons for the distinct TRAF6 dependency between the antiviral response to WT SeV and the response to mutant SeVs remain to be elucidated. To confirm the function of TRAF6 against RNA virus infection, we used other RNA viruses NDV and EMCV. Replication of NDV and EMCV was significantly higher in Traf6-/- MEF cells than in Traf6+/+ MEF cells (Figure 2B and 2C). Moreover, in response to NDV infection, NF-kappaB activation was abrogated (Figure 3C), and production of type I IFNs was significantly lower in the absence of TRAF6 (Figure 2B and 4E). EMCV infection-induced activation of the IFNbeta promoter was also impaired in Traf6-/- MEF cells (Figure 1B). It has recently been reported that production of type I IFNs derived from DCs and MEF cells in response to infection with vesicular stomatitis virus (VSV) is significantly lower in the absence of TRAF6 [30]. Therefore, TRAF6 has been shown to be essential for sufficient antiviral responses to infection with four different RNA viruses, leading to the conclusion that TRAF6 is involved in RLH signaling.
###end p 49
###begin p 50
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf3</italic>
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Oganesyan1">[24]</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Saha1">[25]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Xu1">[22]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Saha1">[25]</xref>
###xml 655 671 651 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3B and 3C</xref>
###xml 792 804 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I&#954;B&#945;</italic>
###xml 804 808 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Oganesyan1">[24]</xref>
###xml 810 814 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Saha1">[25]</xref>
###xml 950 953 930 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Bowie1">[3]</xref>
Although TRAF6 is clearly involved in the RLH signaling pathway, inhibition of IFN production in response to RNA virus infection due to TRAF6 deficiency was partial in the present study, suggesting the presence of TRAF6-dependent and -independent pathways leading to IFN production. Similarly, type I IFN production has been reported to be partially blocked in Traf3-/- MEF cells [24], [25]. Furthermore, TRAF3 and TRAF6 independently bind to their own specific binding sites in IPS-1 [22], [25]. Therefore, TRAF3 may regulate the TRAF6-independent production of type I IFNs. We also showed that RLH pathway-dependent NF-kappaB activation requires TRAF6 (Figure 3B and 3C), whereas TRAF3 deficiency does not affect the activation of NF-kappaB or expression of NF-kappaB target genes, such as IkappaBalpha[24], [25]. Furthermore, TRAF6-induced activation of IRF is likely to be specific for IRF7, while TRAF3 is thought to activate both IRF3 and IRF7 [3]. These results strongly suggest that the TRAF6- and TRAF3-dependent pathways are likely to bifurcate at IPS-1, but to converge later at IRF7 in order to co-operatively induce sufficient production of type I IFNs during RLH signaling.
###end p 50
###begin p 51
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sharma1">[27]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai2">[12]</xref>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ning1">[52]</xref>
###xml 627 636 627 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g003">Figure 3F</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">7D</xref>
###xml 500 518 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Since phosphorylation of IRF7 is thought to be catalyzed by TBK1/IKKi [27], TRAF6 may activate TBK1/IKKi in response to cytosolic RNA and DNA. A previous study has shown that TRAF6 induces the polyubiquitination of IRF7 when both are transiently transfected into HEK293T cells [12]. It has been also reported that Lys-444, -446, and -452 of IRF7 are critical ubiquitin sites catalyzed by TRAF6, when IRF7 is activated by latent membrane protein 1 (LMP1), a member of the TNF receptor superfamily, of Epstein-Barr virus [52]. In contrast, we show here that E3 ligase activity of TRAF6 is not required for production type I IFN (Figure 3F and 7D), which strongly suggests that Lys-63-linked polyubiquitination is not involved in IRF7 activation. Further studies are required in order to elucidate the details of TRAF6-mediated IRF7 activation.
###end p 51
###begin p 52
###xml 118 122 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Shim1">[50]</xref>
###xml 124 128 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Huang1">[51]</xref>
###xml 130 134 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sato2">[53]</xref>
###xml 209 212 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Lamothe1">[8]</xref>
###xml 647 655 631 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6</xref>
###xml 787 796 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g006">Figure 6D</xref>
###xml 1016 1020 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yoshida1">[30]</xref>
###xml 1098 1103 1074 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk1</italic>
###xml 1103 1106 1079 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1118 1128 1094 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005674.s004">Figure S4A</xref>
###xml 1211 1221 1187 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005674.s004">Figure S4B</xref>
###xml 1643 1647 1611 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takahashi1">[54]</xref>
###xml 673 676 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1070 1073 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
Previous studies have shown that TAK1 and MEKK3 are involved in NF-kappaB activation in TLR family signaling pathways [50], [51], [53], and that the E3 ligase activity of TRAF6 is required for TAK1 activation [8]. Since RLH-induced NF-kappaB activation requires the RING domain of TRAF6, the polyubiquitination reaction may also be involved in NF-kappaB activation in response to viral infection. Therefore, we postulated that TAK1 and MEKK3 are candidate MAP3Ks acting downstream of TRAF6 to activate IKK during RLH signaling. Surprisingly, TAK1 and MEKK3 were not essential for RLH-mediated NF-kappaB activation and production of IL-6 and IFNs (Figure 6). Interestingly, NDV infection-induced production of type I IFNs was slightly higher in the absence of MEKK3 than in its presence (Figure 6D). During the preparation of this manuscript, Yoshida et al. reported that TRAF6 is involved in the RLH antiviral pathway, and that MEKK1 acts downstream of TRAF6 to induce NF-kappaB activation and type I IFN production [30]. However, activation of NF-kappaB in response to NDV infection was normal in Mekk1-/- MEF cells (Figure S4A), whereas production of type I IFNs was slightly reduced in the absence of MEKK1 (Figure S4B). These results clearly indicate that the pathway downstream of TRAF6 in RLH signaling is distinct from that associated with TLR family signaling Although MEKK1 and MEKK3 are not essential for RLH-induced activation of NF-kappaB, they may be involved in fine-tuning the level of IFN production in response to viral infection. It has been previously reported that caspase-8 is involved in RLH-induced NF-kappaB activation [54]. Therefore, one possible mechanism is that TRAF6 activates caspase-8, which leads to NF-kappaB activation. However, further studies are needed to clarify the molecular mechanisms responsible for TRAF6-induced NF-kappaB activation during RLH signaling.
###end p 52
###begin p 53
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishii1">[31]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Takaoka2">[34]</xref>
###xml 415 424 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7A</xref>
###xml 537 550 533 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g007">Figure 7B, 7C</xref>
###xml 552 561 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005674-g008">8A and 8B</xref>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sun1">[35]</xref>
###xml 767 771 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kumar1">[36]</xref>
###xml 923 927 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Burckstummer1">[55]</xref>
###xml 928 932 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Roberts1">[58]</xref>
Recent studies have demonstrated that cytosolic DNA is recognized by cytosolic DNA sensors and that antiviral responses are induced by signals mediated by TBK1/IKKi, which is distinct from the signal pathway downstream of TLR9, for which DNA recognition occurs at endosomes [31]-[34]. Here we demonstrate that TRAF6 is involved in antiviral responses induced by B-DNA, including production of IL-6 and type I IFNs (Figure 7A). In the cytosolic DNA-induced pathway, TRAF6 regulates activation of NF-kappaB and IRF7, but not that of IRF3 (Figure 7B, 7C, 8A and 8B), similar to the role of TRAF6 in RLH-mediated pathways. However, the molecular mechanisms responsible for transducing antiviral signals are likely to differ between the RNA and DNA sensing pathways [35], [36]. Absent in melanoma 2 (AIM2) has recently been identified as a cytoplasmic DNA sensor, which activates caspase-1 leading to maturation of pro-IL-1beta [55]-[58]. Although AIM2 is thought to be involved in NF-kappaB activation but not in IFNbeta production in response to cytoplasmic dsDNA, the precise molecular mechanisms of the cytosolic DNA sensing system remain to be elucidated.
###end p 53
###begin p 54
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kumagai1">[5]</xref>
###xml 324 328 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Gohda1">[59]</xref>
###xml 400 404 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Hacker1">[60]</xref>
###xml 890 894 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ahonen1">[61]</xref>
###xml 901 905 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Naito1">[62]</xref>
###xml 907 911 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Lomaga1">[63]</xref>
###xml 921 925 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-King1">[64]</xref>
In response to systemic viral infection, pDCs produce type I IFNs by recognizing viral nucleic acids through TLR7 and TLR9, while production of type I IFNs in cDCs depends on RLH and cytosolic DNA sensors [5]. TRAF6 is indispensable not only for NF-kappaB activation and the resulting induction of proinflammatory cytokines [59], but also for production of type I IFNs during TLR7 and TLR9 signaling [60]. In the present report, we demonstrate that TRAF6 is involved in the cytosolic RNA- and DNA-induced production of proinflammatory cytokines and type I IFNs. Thus, TRAF6 makes crucial contributions to antiviral innate immune responses by sensing not only viral nucleic acids encapsulated in endosomes but also those present in the cytosol. In addition to its role in innate immune responses, TRAF6 is essential for establishing the acquired immune system as a signal transducer of CD40 [61], RANK [62], [63], and TCR [64], indicating that TRAF6 is a key molecule for the entire immune system. Therefore, a further understanding of the molecular mechanism associated with TRAF6-mediated signal transduction is required in order to enable the development of therapies against various immune diseases.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, cell culture, and viruses
###end title 56
###begin p 57
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Naito1">[62]</xref>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Traf6</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk1</italic>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Yujiri1">[65]</xref>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mekk3</italic>
###xml 159 162 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Huang1">[51]</xref>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tak1</italic>
###xml 176 179 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sato2">[53]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato2">[37]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato4">[66]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Tanaka1">[67]</xref>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 312 315 <span type="species:ncbi:11191">SeV</span>
###xml 399 402 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 483 487 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 580 585 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
The generation of Traf6-/- mice has been described [62]. Primary Traf6-/- MEF cells and C57BL/6 MEF cells were prepared from E14.5 embryos. Mekk1-/-[65], Mekk3-/-[51], and Tak1-/-[53] MEF cells were prepared as described. MEF cells, HEK293T cells, and Vero cells were cultured in DMEM supplemented with 10% FBS. SeV WT (Z strain), Cm, and V-strains were prepared as previously described [37], [66]. NDV was kindly provided by T. Abe and Y. Matsuura (Osaka University, Osaka, Japan). EMCV was kindly provided by F. Taguchi (National Institute of Infectious Disease, Tokyo, Japan). HSV-1 was prepared as previously described [67].
###end p 57
###begin title 58
Plasmids
###end title 58
###begin p 59
###xml 913 917 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishida1">[68]</xref>
###xml 936 940 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Nomura1">[69]</xref>
###xml 959 963 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Shimada1">[70]</xref>
###xml 982 986 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Sato3">[71]</xref>
###xml 1005 1009 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kawai2">[12]</xref>
###xml 1029 1033 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Ishida1">[68]</xref>
###xml 476 481 <span type="species:ncbi:10090">Mouse</span>
The plasmids p125-luc (IFNbeta-luc), p55C1B-luc (ISRE-luc), pEF-FLAG-RIG-IN, and pEF-FLAG-MDA5N were kindly provided by T. Fujita (Kyoto University, Kyoto, Japan). The plasmid pcDNA3-FLAG-MAVS (IPS-1) was kindly provided by Z. J. Chen (University of Texas Southwestern Medical Center, Texas, USA). The plasmid pGL-3kappaB-luc (NF-kappaB-luc) was constructed by inserting three kappaB sites and a thymidine kinase (tk) promoter into the appropriate sites in pGL4.12 (Promega). Mouse cDNA for IRF3 was amplified from MEF cells using gene-specific PCR primers and inserted into the XhoI/NotI site of the pME vector with an N-terminal FLAG tag. The retroviral vectors encoding TAK1, MEKK3, TRAF6, T6Rm, and IRF7 were constructed by inserting each cDNA generated by PCR into the appropriate sites in the pMx-puro vector. The beta-galactosidase expression vector driven by the beta-actin promoter (beta-actin-beta-gal) [68], pEFBOS-FLAG-TANK [69], pEFBOS-FLAG-IKKi [70], pEFBOS-FLAG-TBK1 [71], pFLAG-CMV2-mIRF7 [12], and pME-Myc-TRAF6 [68] were prepared as previously described.
###end p 59
###begin title 60
Infection of virus and transfection of RNA and DNA
###end title 60
###begin p 61
###xml 393 401 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 429 433 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato3">[39]</xref>
###xml 521 525 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Stetson1">[33]</xref>
###xml 104 107 <span type="species:ncbi:11191">SeV</span>
###xml 109 112 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 141 146 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 277 280 <span type="species:ncbi:11191">SeV</span>
###xml 282 285 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 290 295 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
For viral infection, cells were incubated with viruses at the indicated MOI for 1 h in MEM without FBS (SeV, NDV) or Medium 199 with 1% FBS (HSV-1) before replacement with DMEM containing 10% FBS. Excess virus was washed away 1 hr after infection. MEF cells were infected with SeV, NDV, or HSV-1 for 24 h or transfected with 10 microg/ml of poly I:C (InvivoGen, San Diego, CA), 1 microg/ml of in vitro-transcribed dsRNA (600 bp) [39], 10 microg/ml of B-DNA (poly(dA-dT)-poly(dT-dA), Sigma-Aldrich, St. Louis, MO), or ISD [33] for 12 h using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
###end p 61
###begin title 62
ELISA and Real-time PCR
###end title 62
###begin p 63
###xml 587 597 577 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 599 603 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ifnb</italic>
###xml 605 610 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IkBa,</italic>
###xml 615 624 602 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">non-ifna4</italic>
###xml 656 660 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Wang2">[41]</xref>
Culture supernatants were collected and analyzed by ELISA to measure production of IL-6 (R&D systems, Minneapolis, MN), IFNalpha, and IFNbeta (PBL Biomedical Laboratories, Piscataway, NJ). Total RNA was isolated from cells using Trizol Reagent (Invitrogen) and cDNA synthesis was performed using PrimeScript II (Takara Bio, Shiga, Japan). Real-time RT-PCR analysis was performed using the 7300 system (Applied Biosystems, Foster City, CA) and SYBR Green (Roche, Mannheim, Germany). The level of beta-actin expression in each sample was used to standardize the data. The primers used for beta-actin, ifnb, IkBa, and non-ifna4 have been previously described [41].
###end p 63
###begin title 64
Luciferase assay
###end title 64
###begin p 65
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1048 1079 1031 1062 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCACGAAGAGAUAAUGGAUGCCAAA-3&#8242;</named-content>
###xml 1130 1134 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Bidere1">[72]</xref>
###xml 297 301 <span type="species:ncbi:12104?1.0">EMCV</span>
Using Lipofectamine 2000, we transiently transfected MEF cells with reporter plasmids and Renilla luciferase plasmid as an internal control in the presence or absence of expression plasmid for various activator of RLH pathways. At 48 h after the initial transfection, MEF cells were infected with EMCV (MOI = 1) for 20 h, or transfected with either poly I:C (10 microg/ml) or B-DNA (10 microg/ml) for 6 h using Lipofectamine 2000. Subsequently cells were analyzed in dual luciferase reporter assays (Promega, Madison, WI). HEK293T cells were transfected with the TRAF6-specific siRNA (Invitrogen) using RNAi MAX (Invitrogen). At 24 h after siRNA treatment, cells were transiently transfected with ISRE-luc, various expression plasmids, and beta-actin-beta-gal as an internal control using the calcium phosphate method. At 24 h after transfection, the cells were lysed and subjected to the PicaGene luciferase assay (Toyo Ink, Tokyo, Japan). beta-galactosidase activity was used to standardize the transfection efficiency. The TRAF6-specific siRNA (5'-CCACGAAGAGAUAAUGGAUGCCAAA-3') was used to suppress endogenous TRAF6 expression [72].
###end p 65
###begin title 66
Plaque assay
###end title 66
###begin p 67
###xml 65 68 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 98 102 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 107 112 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 201 204 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 209 214 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 348 351 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 392 397 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 403 407 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 574 577 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 594 599 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 604 608 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 661 664 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 693 698 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 703 707 <span type="species:ncbi:12104?1.0">EMCV</span>
Culture supernatants were collected from MEF cells infected with NDV for the indicated times. For EMCV and HSV-1, infected cells were freeze-thawed, and the supernatants were used. For plaque assay of NDV and HSV-1, Vero cells were then incubated with serial dilutions of the supernatants for 1 h, and then overlaid with 1% low-melting agarose for NDV or Medium 199 with human g-globulin for HSV-1. For EMCV, L929 cells were used instead of Vero cells and overlaid with 1% carboxymethylcellulose. After incubation for 48 h, the cells were fixed with 4% paraformaldehyde for NDV or methanol for HSV-1 and EMCV. Cells were then stained with 0.05% amido black for NDV or 0.05% crystal violet for HSV-1 and EMCV. Numbers of plaques were counted in order to calculate the viral titer.
###end p 67
###begin title 68
Electrophoretic mobility shift assay (EMSA)
###end title 68
###begin p 69
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 496 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 755 757 747 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 854 886 838 870 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCTTCAGAGGGGACTTTCCGAGAGG-3&#8242;</named-content>
###xml 888 920 872 904 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGACCTCTCGGAAAGTCCCCTCTGA-3&#8242;</named-content>
###xml 1627 1659 1595 1627 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCTTCGCTTGATGACTCAGCCGGAA-3&#8242;</named-content>
###xml 1661 1693 1629 1661 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCCTTCCGGCTGAGTCATCAAGCG-3&#8242;</named-content>
###xml 29 32 <span type="species:ncbi:11191">SeV</span>
###xml 50 53 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1145 1151 <span type="species:ncbi:9913">bovine</span>
MEF cells were infected with SeV Cm (MOI = 10) or NDV (MOI = 5) and harvested at the indicate times. Cells were suspended in hypotonic buffer [10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol (DTT), and 0.4 microM phenylmethylsulfonyl fluoride (PMSF)]. The suspension was maintained on ice for 20 min, and the cells were then disrupted by pipetting. The supernatant was removed, and the pelleted nuclei were incubated with extraction buffer [20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 0.4 microM PMSF and 25% glycerol]. The suspension was incubated on ice for 20 min, and the nuclear extract was obtained from the supernatant. Equal amounts of extracts were incubated for 25 min at room temperature with 32P-labeled oligonucleotide containing the NF-kappaB binding site of the Igkappa light chain gene (5'-AGCTTCAGAGGGGACTTTCCGAGAGG-3', 5'-TCGACCTCTCGGAAAGTCCCCTCTGA-3'), and 0.05 microg/microl of poly dI:dC. Binding reactions were carried out in the following buffer: 15 mM Tris-HCl (pH 7.5), 75 mM NaCl, 1.5 mM EDTA, 1.5 mM DTT, 7.5% glycerol, 0.3% Nonidet P-40 (NP-40), and 1 microg/microl bovine serum albumin (BSA). Electrophoresis was performed in a 4% acrylamide gel at 150 V for 90 min. The gel was then dried and exposed to film (Kodak, Rochester, NY). The supershift assay was performed by addition of anti-FLAG antibody (Sigma-Aldrich) or anti-p65 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) to the binding reaction. The competition assay was performed by addition of unlabeled probe oligonucleotide or an oligonucleotide containing the AP-1 binding site (5'-AGCTTCGCTTGATGACTCAGCCGGAA-3', 5'-GATCCTTCCGGCTGAGTCATCAAGCG-3').
###end p 69
###begin title 70
Native PAGE
###end title 70
###begin p 71
###xml 258 259 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 261 262 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 36 39 <span type="species:ncbi:11191">SeV</span>
###xml 57 60 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 1009 1020 <span type="species:ncbi:3704">horseradish</span>
###xml 1049 1055 <span type="species:ncbi:9793">donkey</span>
###xml 1061 1067 <span type="species:ncbi:9986">rabbit</span>
MEF cells were infected with either SeV Cm (MOI = 10) or NDV (MOI = 5), or transfected with 10 microg/ml of poly I:C or B-DNA for the indicated times. Cell lysates were prepared in TNE buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 m Na3VO4, 1 mM PMSF]. A 7.5% native acrylamide gel was pre-run at 40 mA for 30 min, then loaded with samples and run at 25 mA for 50 min. The upper chamber buffer was Tris-HCl (pH 8.4), 192 mM glycine, and 0.2% sodium deoxycholate; the lower chamber buffer was Tris-HCl (pH 8.4) and 192 mM glycine. The proteins on the PAGE gel were blotted onto Immobilon-P PVDF membrane (Millipore, Bedford, MA) in transfer buffer [24 mM Tris-HCl (pH 8.4), 192 mM glycine, 20% methanol] at 100 mA for 60 min. The membrane was blocked for 1 h with TBST [20 mM Tris-HCl (pH 7.4), 75 mM NaCl, 0.05% Tween-20] containing 5% nonfat dry milk, and then incubated for 1 h with anti-IRF3 antibody (Zymed, Carlsbad, CA) in blocking solution. Next, the membrane was incubated with horseradish peroxidase (HRP)-conjugated donkey anti-rabbit IgG (GE Healthcare, Buckinghamshire, UK) in blocking solution for 1 h. After three washes, the proteins were visualized using the ECL system (GE Healthcare) and the membrane was exposed to Hyperfilm ECL (GE Healthcare).
###end p 71
###begin title 72
Immunoprecipitation assay
###end title 72
###begin p 73
HEK293T cells were transfected with pME-Myc-TRAF6 together with various FLAG-tagged expression plasmids using the calcium phosphate method. At 48 h after transfection, cell lysates were prepared in TNE buffer and incubated with anti-FLAG antibody (Sigma-Aldrich) at 4degreesC for 1 h. Protein G sepharose (GE Healthcare) was then added to the cell lysates, and the mixture was incubated for 1 h. After three washes, the immunoprecipitates were boiled in SDS sample buffer for 10 min and analyzed by immunoblotting.
###end p 73
###begin title 74
Immunoblotting
###end title 74
###begin p 75
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kato4">[66]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Huang1">[51]</xref>
###xml 506 509 <span type="species:ncbi:11191">SeV</span>
###xml 752 758 <span type="species:ncbi:9793">donkey</span>
###xml 764 770 <span type="species:ncbi:9986">rabbit</span>
###xml 778 783 <span type="species:ncbi:9940">sheep</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
The samples were separated in a 7.5% gel and then transferred to an Immobilon-P PVDF membrane in transfer buffer. The membrane was blocked in TBST containing 5% nonfat dry milk for 1 h, and then incubated in blocking solution or TBST containing 5% BSA for 1 h with one of the following antibodies: anti-FLAG (Sigma-Aldrich); anti-Myc, anti-TRAF6, anti-hIRF7, anti-TAK1 (Santa Cruz Biotechnology); anti-p-JNK (Cell Signaling, Danvers, MA); anti-tubulin (Calbiochem, San Diego, CA); anti-mIRF7 (Zymed); anti-SeV C (prepared as described) [66]; anti-p-hIRF7 (kindly provided by John Hiscott (McGill University, Montreal, Canada); or anti-MEKK3 (prepared as described) [51]. The membrane was then incubated in blocking solution for 1 h with HRP-conjugated donkey anti-rabbit IgG or sheep anti-mouse IgG (GE Healthcare). After three washes, the proteins were visualized by the ECL system (GE Healthcare) and the membrane was exposed to Hyperfilm ECL (GE Healthcare). For quantification of bands visualized in immunoblotting using anti-p-hIRF7 and anti-hIRF7 antibodies, images of chemiluminescent signals were captured by LAS-4000 (Fuji film, Tokyo, Japan) and quantified using Photoshop software (Adobe Systems, San Jose, CA).
###end p 75
###begin title 76
Retrovirus-mediated gene transfer
###end title 76
###begin p 77
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005674-Kitamura1">[73]</xref>
The packaging cell line, Plate-E cells, were transfected with one of the following retroviral vectors (pMx-puro, pMx-hIRF7-puro, pMX-mIRF7-puro, pMx-TAK1-puro, pMx-MEKK3-puro, pMx-TRAF6-puro, pMx-T6Rm-puro) [73]. At 48 h after transfection, the culture medium was collected and used to prepare virus stocks. MEF cells were incubated for 4 h with virus stock containing 10 microg/ml of polybrene. Infected MEF cells were then cultured for 1 day, and then cultured for an additional 2 days with 2 microg/ml of puromycin to remove uninfected cells.
###end p 77
###begin title 78
Statistical analyses
###end title 78
###begin p 79
Statistical significance was determined using Student's t-test. A P value less than 0.05 was considered statistically significant.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
###xml 56 68 <span type="species:ncbi:11191">Sendai virus</span>
###xml 120 123 <span type="species:ncbi:11191">SeV</span>
TRAF6 contributes to reduced expression of C protein of Sendai virus. Traf6+/+ or Traf6-/- MEF cells were infected with SeV Cm (MOI = 10) for the indicated times. Cell lysates were then prepared and analyzed for viral C protein expression by immunoblotting using anti-C protein serum.
###end p 81
###begin p 82
(0.24 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 34 37 <span type="species:ncbi:11191">SeV</span>
###xml 149 152 <span type="species:ncbi:11191">SeV</span>
Activation of IRF3 in response to SeV Cm infection was minimally affected in the absence of TRAF6. Traf6+/+ or Traf6-/- MEF cells were infected with SeV Cm (MOI = 10) for the indicated times. Cell lysates were then prepared, and dimerization of IRF3 was analyzed by native PAGE. Immunoblot analysis was performed using anti-IRF3 antibody.
###end p 84
###begin p 85
(0.31 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 93 96 <span type="species:ncbi:11191">SeV</span>
###xml 100 103 <span type="species:ncbi:11191">SeV</span>
###xml 158 161 <span type="species:ncbi:11191">SeV</span>
Comparison of the production of IL-6 and type I IFNs in response to infection with wild-type SeV or SeV Cm. Traf6+/+ or Traf6-/- MEF cells were infected with SeV WT or Cm (MOI = 10) for 24 h. The amounts of IL-6 (left), IFNalpha (middle), and IFNbeta (right) in the culture media were measured by ELISA. Results indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. ND, not detected. NS, not significant. * = P<0.05. ** = P<0.05.
###end p 87
###begin p 88
(0.20 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 104 107 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 287 290 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
MEKK1 is not essential in RLH-mediated pathways. (A) Mekk1+/+ and Mekk1-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. EMSAs were then performed. Lack of Mekk1 expression in Mekk1-/- MEF cells was confirmed. (B) Mekk1+/+ and Mekk1-/- MEF cells were infected with NDV (MOI = 5) for the indicated times. Expression of the ifnb (left), non-ifna4 (middle), and IkBa (right) genes was assessed by real-time PCR. The results indicate the mean+/-SD of triplicate determinations and are representative of two independent experiments. NS, not significant. ** = P<0.05.
###end p 90
###begin p 91
(0.56 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
###xml 139 142 <span type="species:ncbi:11176?0.9656862745098039">NDV</span>
###xml 159 163 <span type="species:ncbi:12104?1.0">EMCV</span>
We thank Ms. K. Shimizu, M. Hashimoto, J. Kuritani, and K. Semba for secretarial assistance. We are grateful to T. Abe and Y. Matsuura for NDV, F. Taguchi for EMCV, T. Fujita for p125-luc, p55C1B-luc, pEF-FLAG-RIG-IN and pEF-FLAG-MDA5N, Z. J. Chen for pcDNA3-FLAG-MAVS, and J. Hiscott for anti-p-hIRF7 antibody.
###end p 93
###begin title 94
References
###end title 94
###begin article-title 95
Pathogen recognition and innate immunity.
###end article-title 95
###begin article-title 96
Innate recognition of viruses.
###end article-title 96
###begin article-title 97
Viral evasion and subversion of pattern-recognition receptor signalling.
###end article-title 97
###begin article-title 98
Cell type-specific involvement of RIG-I in antiviral response.
###end article-title 98
###begin article-title 99
Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses.
###end article-title 99
###begin article-title 100
Signaling to NF-kappaB by Toll-like receptors.
###end article-title 100
###begin article-title 101
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
###end article-title 101
###begin article-title 102
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.
###end article-title 102
###begin article-title 103
TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
###end article-title 103
###begin article-title 104
TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.
###end article-title 104
###begin article-title 105
Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
###end article-title 105
###begin article-title 106
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.
###end article-title 106
###begin article-title 107
Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.
###end article-title 107
###begin article-title 108
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
###end article-title 108
###begin article-title 109
IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.
###end article-title 109
###begin article-title 110
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.
###end article-title 110
###begin article-title 111
Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.
###end article-title 111
###begin article-title 112
5'-Triphosphate RNA is the ligand for RIG-I.
###end article-title 112
###begin article-title 113
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.
###end article-title 113
###begin article-title 114
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.
###end article-title 114
###begin article-title 115
Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.
###end article-title 115
###begin article-title 116
VISA is an adapter protein required for virus-triggered IFN-beta signaling.
###end article-title 116
###begin article-title 117
###xml 79 96 <span type="species:ncbi:11103">hepatitis C virus</span>
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.
###end article-title 117
###begin article-title 118
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
###end article-title 118
###begin article-title 119
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.
###end article-title 119
###begin article-title 120
IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
###end article-title 120
###begin article-title 121
Triggering the interferon antiviral response through an IKK-related pathway.
###end article-title 121
###begin article-title 122
The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.
###end article-title 122
###begin article-title 123
Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7.
###end article-title 123
###begin article-title 124
TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.
###end article-title 124
###begin article-title 125
Innate immune recognition of, and regulation by, DNA.
###end article-title 125
###begin article-title 126
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.
###end article-title 126
###begin article-title 127
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response.
###end article-title 127
###begin article-title 128
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.
###end article-title 128
###begin article-title 129
The specific and essential role of MAVS in antiviral innate immune responses.
###end article-title 129
###begin article-title 130
Essential role of IPS-1 in innate immune responses against RNA viruses.
###end article-title 130
###begin article-title 131
###xml 46 58 <span type="species:ncbi:11191">Sendai virus</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.
###end article-title 131
###begin article-title 132
###xml 20 32 <span type="species:ncbi:11191">Sendai virus</span>
C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production.
###end article-title 132
###begin article-title 133
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.
###end article-title 133
###begin article-title 134
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.
###end article-title 134
###begin article-title 135
Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression.
###end article-title 135
###begin article-title 136
The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.
###end article-title 136
###begin article-title 137
IRF-7 is the master regulator of type-I interferon-dependent immune responses.
###end article-title 137
###begin article-title 138
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.
###end article-title 138
###begin article-title 139
Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
###end article-title 139
###begin article-title 140
Regulation of IRF7 through cell type-specific protein stability.
###end article-title 140
###begin article-title 141
Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.
###end article-title 141
###begin article-title 142
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7.
###end article-title 142
###begin article-title 143
Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK.
###end article-title 143
###begin article-title 144
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
###end article-title 144
###begin article-title 145
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
###end article-title 145
###begin article-title 146
TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.
###end article-title 146
###begin article-title 147
Essential function for the kinase TAK1 in innate and adaptive immune responses.
###end article-title 147
###begin article-title 148
Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA.
###end article-title 148
###begin article-title 149
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome.
###end article-title 149
###begin article-title 150
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA.
###end article-title 150
###begin article-title 151
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC.
###end article-title 151
###begin article-title 152
HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA.
###end article-title 152
###begin article-title 153
Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
###end article-title 153
###begin article-title 154
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
###end article-title 154
###begin article-title 155
The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.
###end article-title 155
###begin article-title 156
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.
###end article-title 156
###begin article-title 157
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
###end article-title 157
###begin article-title 158
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.
###end article-title 158
###begin article-title 159
MEK kinase 1 interacts with focal adhesion kinase and regulates insulin receptor substrate-1 expression.
###end article-title 159
###begin article-title 160
###xml 19 31 <span type="species:ncbi:11191">Sendai virus</span>
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.
###end article-title 160
###begin article-title 161
###xml 106 133 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo.
###end article-title 161
###begin article-title 162
Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
###end article-title 162
###begin article-title 163
NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.
###end article-title 163
###begin article-title 164
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.
###end article-title 164
###begin article-title 165
Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
###end article-title 165
###begin article-title 166
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
###end article-title 166
###begin article-title 167
New experimental approaches in retrovirus-mediated expression screening.
###end article-title 167
###begin p 168
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 168
###begin p 169
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (T.A. and J.I.) and Young Scientists B (J.G.) from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 169

